Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Juan Xu, Yuquan Chen, Mengmeng Yue, Jianxing Yu, Fuyi Han, Li Xu & Zhujun Shao. (2022) Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Diego Piccioli, Erika Bartolini & Francesca Micoli. (2022) GMMA as a ‘plug and play’ technology to tackle infectious disease to improve global health: context and perspectives for the future. Expert Review of Vaccines 21:2, pages 163-172.
Read now
Read now
Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, Bradford D. Gessner, Melvin Kohn, Ron Dagan, Daniel C. Payne, Laia Bruni, Andrew J. Pollard, Adolfo García-Sastre, Denise L. Faustman, Albert Osterhaus, Robb Butler, Francisco Giménez Sánchez, Francisco Álvarez, Myrsini Kaforou, Xabier Bello & Federico Martinón-Torres. (2021) TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Human Vaccines & Immunotherapeutics 17:3, pages 759-772.
Read now
Read now
Federico Martinón-Torres, Terry Nolan, Daniela Toneatto & Angelika Banzhoff. (2019) Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults. Human Vaccines & Immunotherapeutics 15:12, pages 2940-2951.
Read now
Read now
Seong-Beom Park, Hyun-Jin Kim & Hee-Jin Cheong. (2019) Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations. Expert Review of Vaccines 18:6, pages 587-596.
Read now
Read now
Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro & Federico Martinón-Torres. (2019) Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and Drug Resistance 12, pages 3169-3188.
Read now
Read now
Alessia Biolchi, Sara Tomei, Laura Santini, Jo Anne Welsch, Daniela Toneatto, Nikolaos Gaitatzis, Xilian Bai, Ray Borrow, Marzia Monica Giuliani, Elena Mori & Mariagrazia Pizza. (2019) Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules. Human Vaccines & Immunotherapeutics 15:3, pages 725-731.
Read now
Read now
Rino Rappuoli, Mariagrazia Pizza, Vega Masignani & Kumaran Vadivelu. (2018) Meningococcal B vaccine (4CMenB): the journey from research to real world experience. Expert Review of Vaccines 17:12, pages 1111-1121.
Read now
Read now
Xavier Sáez-Llorens, Johnny Beltran-Rodriguez, Jose M. Novoa Pizarro, Ilhem Mensi, Pavitra Keshavan & Daniela Toneatto. (2018) Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults. Human Vaccines & Immunotherapeutics 14:5, pages 1161-1174.
Read now
Read now
Nan-Chang Chiu, Li-Min Huang, Arnold Willemsen, Chiranjiwi Bhusal, Ashwani Kumar Arora, Zenaida Reynoso Mojares & Daniela Toneatto. (2018) Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study. Human Vaccines & Immunotherapeutics 14:5, pages 1075-1083.
Read now
Read now
Andrew Vyse, Gillian Ellsbury & Harish Madhava. (2018) Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines 17:3, pages 229-237.
Read now
Read now
Articles from other publishers (39)
Marta Ijalba Martínez, María Dolores Lasheras Carbajo, Sara Santos Sanz & Diana Gómez Barroso. (2023) Aceptación y desigualdades socioeconómicas en la vacunación frente a meningococo B en la Comunidad de Madrid en el periodo anterior a su inclusión en el calendario. Anales de Pediatría 99:6, pages 393-402.
Crossref
Crossref
Marta Ijalba Martínez, María Dolores Lasheras Carbajo, Sara Santos Sanz & Diana Gómez Barroso. (2023) Acceptance and socioeconomic inequalities in meningococcal B vaccination in the community of Madrid prior to its inclusion in the immunization schedule. Anales de Pediatría (English Edition).
Crossref
Crossref
Ishita Gupta, Ola Hussein, Konduru Seetharama Sastry, Salim Bougarn, Neha Gopinath, Evonne Chin-Smith, Yashi Sinha, Hesham Mohamed Korashy & Cristina Maccalli. (2023) Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications. Advances in Cancer Biology - Metastasis 8, pages 100107.
Crossref
Crossref
Caroline Thng, Evgeny A. Semchenko, Ian Hughes, Maree O’Sullivan & Kate L. Seib. (2023) An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol. BMC Public Health 23:1.
Crossref
Crossref
Farhat Fatima, Satarupa Kumar & Anupam Das. (2022) Vaccines against sexually transmitted infections: an update. Clinical and Experimental Dermatology 47:8, pages 1454-1463.
Crossref
Crossref
Stavros A. Maurakis & Cynthia Nau Cornelissen. (2022) Recent Progress Towards a Gonococcal Vaccine. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei & Xiawei Wei. (2022) Cancer vaccines as promising immuno-therapeutics: platforms and current progress. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Vasilica Ungureanu. (2022) Essential things to know about meningococcal disease and its prevention. Medic.ro 1:145, pages 22.
Crossref
Crossref
Bryan van den Broek, Jordy P. M. Coolen, Marien I. de Jonge, Ronald de Groot, Stefanie S. V. Henriet, Jeroen D. Langereis & Michiel van der Flier. (2021) Neisseria meningitidis Serogroup Z Meningitis in a Child With Complement C8 Deficiency and Potential Cross Protection of the MenB-4C Vaccine. Pediatric Infectious Disease Journal 40:11, pages 1019-1022.
Crossref
Crossref
Ethan C. Haese, Van C. Thai & Charlene M. Kahler. (2021) Vaccine Candidates for the Control and Prevention of the Sexually Transmitted Disease Gonorrhea. Vaccines 9:7, pages 804.
Crossref
Crossref
Peter H. Seeberger. (2021) Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach. Chemical Reviews 121:7, pages 3598-3626.
Crossref
Crossref
Jeroen Pollet, Wen-Hsiang Chen & Ulrich Strych. (2021) Recombinant protein vaccines, a proven approach against coronavirus pandemics. Advanced Drug Delivery Reviews 170, pages 71-82.
Crossref
Crossref
Annett Kleinschmidt, Kumaran Vadivelu, Laura Serino, Nina Neidig & Bertrand de Wergifosse. (2021) Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B. npj Vaccines 6:1.
Crossref
Crossref
Alessia Biolchi, Sara Tomei, Laura Santini, Rita La Gaetana, Elena Mori, Patricia Novy, Rino Rappuoli, Rafik Bekkat-Berkani, Marzia Monica Giuliani & Mariagrazia Pizza. (2020) Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents. Pediatric Infectious Disease Journal 40:2, pages e66-e71.
Crossref
Crossref
Mariagrazia Pizza, Rafik Bekkat-Berkani & Rino Rappuoli. (2020) Vaccines against Meningococcal Diseases. Microorganisms 8:10, pages 1521.
Crossref
Crossref
Vasilica Ungureanu. (2020) Invasive meningococcal disease – its importance in human pathology and its prevention. Medic.ro 2:134, pages 38.
Crossref
Crossref
Bryan van den Broek, Michiel van der Flier, Ronald de Groot, Marien I. de Jonge & Jeroen D. Langereis. (2020) Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection. Journal of Innate Immunity 12:2, pages 131-141.
Crossref
Crossref
Kate L. Seib, Andreas F. Haag, Francesca Oriente, Laura Fantappiè, Sara Borghi, Evgeny A. Semchenko, Benjamin L. Schulz, Francesca Ferlicca, Anna Rita Taddei, Marzia M. Giuliani, Mariagrazia Pizza & Isabel Delany. (2019) The meningococcal vaccine antigen GNA2091 is an analogue of YraP and plays key roles in outer membrane stability and virulence. The FASEB Journal 33:11, pages 12324-12335.
Crossref
Crossref
Marcelle Moura Silveira, Alan J.A. McBride & Caroline L. Trotter. (2019) Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme. Vaccine 37:45, pages 6783-6786.
Crossref
Crossref
Evgeny A Semchenko, Aimee Tan, Ray Borrow & Kate L Seib. (2019) The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae. Clinical Infectious Diseases 69:7, pages 1101-1111.
Crossref
Crossref
Gabriela Trzewikoswki de Lima & Elizabeth De Gaspari. (2019)
Study of the Immune Response in the Elderly: Is It Necessary to Develop a Vaccine against
Neisseria meningitidis
for the Aged?
. Journal of Aging Research 2019, pages 1-8.
Crossref
Crossref
Philip S. Watson, Patricia L. Novy & Leonard R. Friedland. (2019) Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease. International Journal of Infectious Diseases 85, pages 22-27.
Crossref
Crossref
Kirsty Le Doare, Beate Kampmann, Johan Vekemans, Paul T Heath, David Goldblatt, Moon H Nahm, Carol Baker, Morven S Edwards, Gaurav Kwatra, Nick Andrews, Shabir A Madhi, Ajoke Sobanjo ter Meulen, Annaliesa S Anderson, Bart Corsaro, Per Fischer & Andrew Gorringe. (2019) Serocorrelates of protection against infant group B streptococcus disease. The Lancet Infectious Diseases 19:5, pages e162-e171.
Crossref
Crossref
Flore AubeyJean-Philippe CorreYouxin KongXiming XuDorian ObinoSylvie GoussardCatherine Lapeyrere, Judith SouphronCedric Couturier, Stéphane Renard & Guillaume Duménil. (2019)
Inhibitors of the
Neisseria meningitidis
PilF ATPase provoke type IV pilus disassembly
. Proceedings of the National Academy of Sciences 116:17, pages 8481-8486.
Crossref
Crossref
T. Tenenbaum, W. Hellenbrand & H. Schroten. (2019) Impfstoffe gegen Meningokokken für das KindesalterVaccines against meningococci for children. Monatsschrift Kinderheilkunde 167:3, pages 196-205.
Crossref
Crossref
Terry Nolan, Maria Elena Santolaya, Ferdinandus de Looze, Helen Marshall, Peter Richmond, Sam Henein, Paul Rheault, Ken Heaton, Kirsten P. Perrett, Hartley Garfield, Anil Gupta, Murdo Ferguson, Diego D'Agostino, Daniela Toneatto & Miguel O'Ryan. (2019) Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine. Vaccine 37:9, pages 1209-1218.
Crossref
Crossref
Kerstin J. Olbrich, Dirk Müller, Sarah Schumacher, Ekkehard Beck, Kinga Meszaros & Florian Koerber. (2018) Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers. Infectious Diseases and Therapy 7:4, pages 421-438.
Crossref
Crossref
María Teresa Pérez-Gracia & Beatriz Suay-García. 2018. Diagnostics to Pathogenomics of Sexually Transmitted Infections. Diagnostics to Pathogenomics of Sexually Transmitted Infections
181
209
.
Alessia Liguori, Lucia Dello Iacono, Giulietta Maruggi, Barbara Benucci, Marcello Merola, Paola Lo Surdo, Jacinto López-Sagaseta, Mariagrazia Pizza, Enrico Malito & Matthew J. Bottomley. (2018) NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies. mBio 9:5.
Crossref
Crossref
Mercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial. Vaccine 36:50, pages 7609-7617.
Crossref
Crossref
Gabriela Trzewikoswki de Lima & Elizabeth De Gaspari. (2018) Individual variability in humoral response of immunized outbred mice and cross-reactivity with prevalent Brazilian Neisseria meningitidis strains. Biologicals 55, pages 19-26.
Crossref
Crossref
Martina Maritan, Daniele Veggi, Roberta Cozzi, Lucia Dello Iacono, Erika Bartolini, Paola Lo Surdo, Giulietta Maruggi, Glen Spraggon, Matthew J. Bottomley & Enrico Malito. (2018) Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody. PLOS ONE 13:8, pages e0201922.
Crossref
Crossref
Jo Anne Welsch, Shelly Senders, Brandon Essink, Thomas Klein, Igor Smolenov, Paola Pedotti, Silvia Barbi, Bikash Verma & Daniela Toneatto. (2018) Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study. Vaccine 36:35, pages 5309-5317.
Crossref
Crossref
Anouk M. Oordt-Speets, Renee Bolijn, Rosa C. van Hoorn, Amit Bhavsar & Moe H. Kyaw. (2018) Global etiology of bacterial meningitis: A systematic review and meta-analysis. PLOS ONE 13:6, pages e0198772.
Crossref
Crossref
Jennifer L. Edwards, Michael P. Jennings & Kate L. Seib. (2018) Neisseria gonorrhoeae vaccine development. Current Opinion in Infectious Diseases 31:3, pages 246-250.
Crossref
Crossref
María Victoria Humbert & Myron Christodoulides. (2018) Immunization with recombinant truncated Neisseria meningitidis -Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae. Vaccine 36:27, pages 3926-3936.
Crossref
Crossref
Ana Rafaela Silva Simões Moura, Cécilia Batmalle Kretz, Ítalo Eustáquio Ferreira, Amélia Maria Pithon Borges Nunes, Ivano de Filippis, José Cássio de Moraes, Mitermayer Galvão Reis, Alan John Alexander McBride, Xin Wang & Leila Carvalho Campos. (2018) Epidemiology and molecular characterization of Neisseria lactamica carried in 11–19 years old students in Salvador, Brazil. International Journal of Medical Microbiology 308:4, pages 454-458.
Crossref
Crossref
Bingqing Zhu, Fenglin Shi, Aiyu Zhang, Xiaofang Sun, Zheng Xu, Li Xu, Yuan Gao, Jing Lv & Zhujun Shao. (2018) Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China. Vaccine 36:15, pages 1983-1989.
Crossref
Crossref
Kate L Seib. (2017) Gonorrhoea vaccines: a step in the right direction. The Lancet 390:10102, pages 1567-1569.
Crossref
Crossref